Meeting
2018 ASCO Annual Meeting
Long-term benefit from tamoxifen therapy for patients with Luminal A and Luminal B breast cancer: Retrospective analysis of the STO-3 trial.
Authors
Linda Lindström
Karolinska Institutet, Stockholm, Sweden
Linda Lindström , Nancy Yu , Adina Iftimi , Christina Yau , Laura van 't Veer , Bo Nordenskjöld , Christopher Benz , Tommy Fornander , Olle Stål , Kamila Czene , Laura Esserman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Clinical Trial Registration Number
STO-3 trial from 1976 no registration# at the time
Citation
J Clin Oncol 36, 2018 (suppl; abstr 541)
DOI
10.1200/JCO.2018.36.15_suppl.541
Abstract #
541
Poster Bd #
33
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Association of metabolic risk factors with breast cancer survival in a population-based cohort.
First Author: Elizabeth Feliciano
Poster
2021 ASCO Annual Meeting
Trends in breast cancer mortality according to molecular subtypes: A population-based study.
First Author: Yunan Han
Poster
2019 ASCO Annual Meeting
In-depth gene expression analysis of premenopausal patients with HR+/HER2− advanced breast cancer (ABC) treated with ribociclib-containing therapy in the Phase III MONALEESA-7 trial.
First Author: Yen-Shen Lu